Team Publications :: Nationwide Children's Hospital

Publications

Center for Vaccines and Immunity

2012

  • San-Juan-Vergara, H., Sampayo-Escobar, V., Reyes, N., Cha, B., Pacheco-Lugo, L., Wong, T., Peeples, M.E., Collins, P.L., Castano, M.E., and Mohapatra, S.S. 2012. Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells.  J Virol. Vol. 86, no. 3. (February): 1832-1843.

2011

  • Freeman ML, Burkum CE, Lanzer KG, Jensen MK, Ahmed M, Yager EJ, Flano E, Winslow GM, Woodland DL, Blackman MA. 2011. Cutting Edge: Activation of virus-specific CD4 T cells throughout gamma-herpesvirus latency.  J Immunol. no. Nov 11 ePub ahead of print. (November 11)
  • Chaiwatpongskorn S, Epand RF, Collins PL, Epand RM and Peeples ME. 2011. Soluble respiratory syncytial virus fusion protein in the fully cleaved, pre-triggered state is triggered by exposure to low ionic strength buffer.  J Virol. Vol. 85, no. 8. (April): 3968-3977. (IF: 5.15)
  • Cush S.S. and Flaño E. 2011. KLRG1+NKG2A+ CD8 T cells mediate protection and participate in memory responses during ?-Herpesvirus infection.  J Immunol. Vol. 7, no. 186. : 4051-4058.
  • Santiago B, McCloud B, Mejias A. 2011. An 11 month old with Pneumonia and rash.  Revista Pediatrica de Panama. (Formally Accepted)
  • Hallak LK, Berger K, Kaspar R, Kwilas A, Montanaro F, and Peeples ME. 2011. Efficient method for site-directed mutagenesis in large plasmids without subcloning.  J Virol. no. (submitted for publication). (Unspecified)
  • Jonathan Honegger and Michael Brady. 2011. Viral Respiratory Infections. In Rudolph's Pediatrics. 22nd ed. Edited by Colin Rudolph, Abraham Rudolph, George Lister, Lewis First, Anne Gershon. New York, New York, USA: McGraw-Hill Publishers.
  • Malykhina O, Yednak MA, Collins PL, Olivo PD, and Peeples ME. 2011. A respiratory syncytial virus replicon that is nonsytotoxic and capable of long-term foreign gene expression.  J Virol. Vol. 85, no. 10. : 4792-4801.
  • Dotson JL; Crandall W; Mousa H; Honegger JR; Denson L; Samson C; Cunningham D; Balint J; Dienhart M; Jaggi P; Carvalho R. 2011. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series.  Inflammatory Bowel Diseases. Vol. 17, no. 1. (January 1): 56. (IF: 4.613)
  • Mejías A and Ramilo O. 2011. The Bacterial-Viral Interactions in Children with Community Acquired Pneumonia.  Ped Infect Dis J. Vol. 30, no. 2.

2010

  • Garcia C, Bhore, R, Soriano-Fallas A, Trost M, Chason R, Ramilo O and Mejías, A. 2010. Risk Factors for Bronchiolitis-related Hospitalizations: Differences between Respiratory Syncytial Virus (RSV) and non-RSV Bronchiolitis.  Pediatrics. Vol. 126, no. 6. (December): e1453-e1460.
  • Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G, Bradley JS,Wade K, Ramilo O, Romero JR, Shelton M, Leach C, Guzman-Cottrill J, Robinson J,Abughali N, Englund J, Griffin J, Jester P, Cloud GA, Whitley RJ. 2010. Safety of Oseltamivir Compared With theAdamantanes in Children Less Than 12 Months of Age.  Pediatr. Infect. Dis. J.. Vol. 29, no. 3 (November 25): 195-198.
  • Torres J.P, Gomez A.M, Khokhar S, Vijay G Bohj V.J, Tagliabue C, Chang M.L, Kiener P.A, Revell P.A, Ramilo O and Mejías A. 2010. Respiratory Syncytial Virus (RSV) RNA Loads in Peripheral Blood Correlates with Disease Severity in Mice.  Respiratory Research. Vol. 11. (September 15): 125.
  • Berry MPR, Gragan CM, McNab FM, Xu Z, Bloch S, Oni T, Wilkinson K, Banchereau R, Skinner J, Wilkinson R, Quinn C, Blankenship D, Dhawan R, Cush J, Mejias A, Ramilo O, Kon O, Pascual V, Banchereau J, Chaussabel D, O'Garra A. 2010. Transcriptional Profiling Reveals an Interferon-Inducible Neutrophil-Driven Signature in Human Tuberculosis.  Nature. Vol. 466, no. 7309. (August 19): 973-977.
  • Dotson JL, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R. 2010. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series.  Inflamm Bowel Dis. (July 19)
  • Kwilas, A.R., Yednak, M.A., Zhang, L., Leisman, R., Collins, P.L., Pickles, R.J., and Peeples, M.E. 2010. Respiratory syncytial virus engineered to express the Cystic Fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human Cystic Fibrosis airway epithelium in vitro.  J Virol. Vol. 84. (June): 7770-7781. (IF: 5.15)
  • Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G, Malik V, Coley B, Clark KR, Li J, Xiao X, Samulski J, McPhee SW, Samulski RJ, Walker CM. 2010. Dystrophin immunity in Duchenne Muscular Dystrophy.  NEJM. Vol. 363, no. 15. : 1429-1437.
  • Malik V, Rodino-Klapac LR, Viollet L, Wall C, King W, Al-Dahhak R, Lewis S, Shilling CJ, Kota J, Serrano-Munuera C, Hayes J, Mahan JD, Campbell KJ, Banwell B, Dasouki M, Watts V, Sivakumar K, Bien-Willner R, Flanigan KM, Sahenk Z, Barohn RJ, Walker CM, and Mendell JR. 2010. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.  Annals Neurol. Vol. 67, no. 6: 771-780.
  • Mejias A and Ramilo O. 2010. RSV and Asthma, what is the evidence?.  Ed. Luzan. Vol. 1: 1-10.
  • Fuller MJ, Shoukry NH, Gushima T, Bowen DG, Callendret B, Campbell KJ, Hasselschwert DL, Hughes AL, Walker CM. 2010. Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.  Hepatology. Vol. 51, no. 2: 378-387.
  • Berry MPR, Graham CM, McNab FM, Xu Z, Bloch S, Oni T, Wilkinson K, Banchereau R, Skinner J, Wilkinson R, Quinn C, Blankenship D, Dhawan R, Cush J, Mejias A, Ramilo O, Kon O, Pascual V, Banchereau J, Chaussabel D, and O'Garra A. Transcriptional Profiling Reveals an Interferon-Inducible Neutrophil-Driven Signature in Human Tuberculosis.  Nature. (In press)
  • Jordan-Villegas A, Chang ML, Ramilo O, Mejias A. 2010. Concomitant respiratory viral infections in Children with Kawasaki Disease.  Ped Infect Dis J. Vol. 29, no. 9: 1-3.
  • Rodino-Klapac LR, Montgomery CL, Bremer WG, Shontz KM, Malik V, Davis N, Sprinkle S, Campbell KJ, Sahenk Z, Clark KR, Walker CM, Mendell JR, and Chicoine LG. 2010. Persistent Expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery.  Mol Ther. Vol. 18, no. 1: 109-117.
  • Weslow-Schmidt, J., Ye, F., Cush, S.S., Stuller, K.A., Blackman, M.A., Flaño, E. 2010. Dendritic cells loaded with tumor B cells elicit broad immunity against murine gamma-herpesvirus 68 but fail to prevent long-term latency.  J Virol. Vol. 84, no. 17. : 8975-8979.
  • Stuller, K.A., Cush, S.S. and Flaño, E. 2010. Persistent ?-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.  J Immunol. Vol. 184, no. 7. : 3850-3856.
  • Mejias A and Ramilo O. 2010. RSV and Asthma, what is the evidence?.  Ed. Luzan. Vol. 1: 1-10.
  • Mendell JR, Rodino-Klapac LR, Rosales XQ, Coley BD, Galloway G, Lewis S, Malik V, Shilling C, Byrne BJ, Conlon T, Campbell KJ, Bremer WG, Taylor LE, Flanigan KM, Gastier-Foster JM, Astbury C, Kota J, Sahenk Z, Walker CM, Clark KR. 2010. Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D.  Ann Neurol. Vol. 68, no. 5. : 629-638.
  • Rodriguez R, Mejias A, and Ramilo O. Acute Bronchiolitis Infections in the Community.  n/a. (In press)
  • Techasaensiri B, Techasaensiri C, Mejias A, McCracken G and Ramilo O. 2010. Viral Co-infections in Children with Invasive Pneumococcal Disease.  Ped Infect Dis J. Vol. 29, no. 6. : 519-523.
  • Grieves, J.L., Jurcisek, J.D., Quist, B., Durbin, R.K., Peeples, M.E., Durbin, J.E., and Bakaletz, L.O. 2010. Mapping the anatomy of respiratory syncytial virus infection in the upper airway in chinchillas (Chinchilla lanigera).  Comparative Medicine. Vol. 60: 225-232.
  • Techasaensiri B, Techasaensiri T, Mejias A, McCracken GH, Ramilo O. 2010. Viral Co-infections in Children with Invasive Pneumococcal Disease.  Ped Infect Dis J. Vol. 29, no. 6: 1-6.
  • Rodriguez R, Mejias A, and Ramilo O. Acute Bronchiolitis Infections in the Community.  n/a. (In press)
  • Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE. 2010. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.  J Virol. Vol. 84, no. 21. : 11515-11522.
  • Gottwein JM, Scheel TK, Callendret B, Li YP, Eccleston HB, Engle RE, Govindarajan S, Satterfield W, Purcell RH, Walker CM, Bukh J. 2010. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.  J Virol. Vol. 84, no. 10: 5277-5293.
  • Jordan-Villegas A, Chang M, Ramilo O, and Mejias A. 2010. Concomitant Respiratory Viral Infection in Children with Kawasaki Disease.  Ped Infect Dis J. Vol. 29, no. 8. : 770-772.
  • Walker CM. 2010. Adaptive immunity to the hepatitis C virus.  Adv Virus Res. Vol. 78. : 43-86.

2009

  • Kota J, Handy CR, Haidet AM, Montgomery CL, Eagle A, Rodino-Klapac LR, Tucker D, Shilling CJ, Therlfall WR, Walker CM, Weisbrode SE, Janssen PML, Clark KR, Sahenk Z, Mendell JR, Kaspar BK. 2009. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates.  Science Translational Medicine. Vol. 1, no. 6. (November): 6-15.
  • Somers CC, Ahmad N, Mejias A, Buckingham SC, Carubelli C, Katz K, Leos N,Gomez AM, Devincenzo JP, Ramilo O, Jafri HS. 2009. Effect of dexamethasone onrespiratory syncytial virus-induced lung inflammation in children: results of arandomized, placebo controlled clinical trial.  Pediatr Allergy Immunol. Vol. 20, no. 5 (April 24): 477-485.
  • Mejias A, Ramilo O. 2009. RSV persistence and recurrent wheezing.  Pediatr Infect Dis J. Vol. 28, no. 6 (March 25): 450-451.
  • Torres J.P, Mejias A, and O. Ramilo. 2009. Legionelosis. In Libro de Infectología de la Asociación Española de Pediatria. Madrid, Spain: Libro de Infectología de la Asociación Española de Pediatria.
  • Hwang, S., Kim, K.S., Flano, E., Wu, T., Tong, L.M., Park, A.N., Song, M.J., Sanchez, D.J., O?Connell, R.M., Cheng, G. and Sun, R. 2009. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response.  Cell Host & Microbe. Vol. 5: 166-178. (IF: 7.436)
  • Hasman, H., Pachucki, C.T., Unal, A., Nguyen, D., Devlin, T., Peeples, M.E., and Kwilas, S.A. 2009. Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4. J. Med. Micro. Vol. 58: 408-413.
  • Ardura MI, Banchereau R, Mejias A, Di Pucchio T, Glaser C, Allantaz F, Pascual V,Banchereau J, Chaussabel D, Ramilo O. 2009. Enhaced monocyte response anddecreased central memoryt T cells in Children with invasive Staphylococcus aureusinfections.  PLoS One. Vol. 4, no. 5: e5446.
  • Ramilo O. 2009. Evolution of prophylaxis: MoAb, siRNA, vaccine, and small molecules.  Paediatr Respir Rev. Vol. 1: 23-25.
  • Mejías A, Bustos R, Ardura M, Ramírez C, Sánchez PJ. 2009. Persistence of Herpes Simplex Virus DNA in Cerebrospinal Fluid of Neonates with Herpes Simplex Virus Encephalitis.  J Perinatol. Vol. 4: 290-296.
  • Lo, M.K., Harcourt, B.H., Mungall, B.A., Tamin, A., Peeples, M.E., Bellini, W.J., and Rota, P.A. 2009. Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V, and W proteins of Nipah virus in virus-infected cells. J. Gen. Virol. Vol. 90: 398-404.
  • Mendell JR, Rodino-Klapac LR, Rosales-Quintero X, Kota J, Coley BD, Galloway G, Craenen JM, Lewis S, Malik V, Shilling C, Byrne BJ, Conlon T, Campbell KJ, Bremer WG, Viollet L, Walker CM, Sahenk Z, Clark KR. 2009. Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins.  Ann Neurol. Vol. 66, no. 3: 290-297.
  • Gal-Tanamy M, Walker CM, Poung S, and Lemon SM. 2009. Hepatitis C. In Vaccines for Biodefense and Emerging and Neglected Diseases. 1st ed. Vol. Chapter 24. Edited by Barrett ADT, Stanberry LW. London, UK: Elsevier. 414-441.
  • Kwilas S, Liesman R.M., Zhang L, Pickles R.J., Walsh E, and Peeples M.E. 2009. Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its tiopism.  J. Virology. Vol. 83, no. 20. : 10710-10718.
  • Stuller, K.A. and Flaño, E. 2009. CD4 T cell-mediated killing in vivo during persistent gammaherpesvirus 68 infection.  J Virol. Vol. 83: 4700-4703. published ahead of print on 25 February 2009, doi:10.1128/JVI.02240-08.. (IF: 5.308)
  • Mejías, A, Rodríguez R and Ramilo, O. 2009. Bronchiolitis. In Pediatric Infectious Disease Guidelines in the Emergency Department. Madrid: Edika Med Editorial. 34-37.
  • Kamili S, Sozzi V, Thompson G, Campbell K, Walker CM, Locarnini S, and Krawczynski K. 2009. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.  Hepatology. Vol. 49, no. 5: 1483-1491.
  • Somers C, Naveed A, Mejías A, Buckingham S. C, Carubelli C, Katz-Gaynor K, Leos N, Gomez A, DeVincenzo J.P, Ramilo O, Jafri H.S. 2009. Effect of dexamethasone on RSV-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial.  Ped Allergy and Immunol. Vol. 20, no. 5: 477-485.
  • Mejias, A and Sanchez JP. 2009. Update on Cytomegalovirus.  Anales Españoles de Pediatría. Vol. 70, no. 6: 517-518.
  • McGillivary, G., Mason, K.M., Jurcisek, J.A., Peeples, M.E., and Bakaletz, L.O. 2009. RSV-induced dysregulation of expression of a mucosal B-defensin augments colonization of the upper airway by nontypeable Haemophilus influenzae.  Cellular Microbiology. Vol. 11, no. 9. : 1399-1408.
  • Velazquez VM, Bowen DG, and Walker CM. 2009. Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector (rAAV)-mediated gene therapy.  Blood. Vol. 113, no. 3: 538-545.
  • Mejías, A, García C, Rodríguez R and Ramilo, O. 2009. Virus respiratorio sincitial y otros virus en las sibilancias del lactante. In en SIBILANCIAS EN EL LACTANTE. Madrid: LUZAN 5 SA. 59-72.
  • Cush, S.S., Flaño, E. 2009. Protective antigen-independent CD8 T cell memory is maintained during ?-herpesvirus persistence.  J Immunol. Vol. 182: 3995-4004. (IF: 6)
  • Ramilo O, Mejias A. 2009. Shifting the Paradigm: Host Gene Signatures for Diagnosis of Infectious Diseases.  Cell and Host Microbe. Vol. 6, no. 3: 199-200.
  • Mejias A, Torres J.P and O. Ramilo. 2009. Virus Respiratorio Sincitial. In Libro de Infectología de la Asociación Española de Pediatría. Madrid, Spain: Libro de Infectología de la Asociación Española de Pediatría.
  • Mejias A. and Ramilo O. 2009. RSV persistence and recurrent wheezing.  Ped Infect Dis J. Vol. 28, no. 6: 450-451.
  • Ramilo O, Mejías A. 2009. Shifting the paradigm; host gene signatures for mdiagnois ofinfectious diseases.  Cell Host Microbe. Vol. 6, no. 3: 199-200.
  • Ardura M, Banchereau R, Mejías A, Di Pucchio T, Glaser C, Allantaz F, Pascual V, Banchereau J, Chaussabel D and Ramilo O. 2009. System Biology Approach to Invasive Staphylococcus Aureus Infections Reveals Reduced Central Memory T cells and Increase Monocytes.  PLOS One. Vol. 4, no. 5: e5446.

2008

  • Ramalingam RK, Meyer-Olson D, Shoukry NH, Bowen DG, Walker CM, Kalams SA. 2008. Kinetic analysis by real-time PCR of hepatitis C virus (HCV)-specific T cells in peripheral blood and liver after challenge with HCV. J Virol. Vol. 82, no. 21. (November): 10487-10492. (IF: 5.332)
  • Uebelhoer L, Han JH, Callendret B, Mateu G, Shoukry NH, Hanson HL, Rice CM, Walker CM, Grakoui A. 2008. Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog. Vol. 4, no. 9. (September 5): e1000143. (IF: 9.336)
  • Velazquez VM, Bowen DG, Walker CM. 2008. Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector (rAAV)-mediated gene therapy. Blood. Vol. 113, no. 3. (June 19): 538-545. (IF: 10.896)
  • Bowen DG, Shoukry NH, Grakoui A, Fuller MJ, Cawthon AG, Dong C, Hasselschwert DL, Brasky KM, Freeman GJ, Seth NP, Wucherpfennig KW, Houghton M, Walker CM. 2008. Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection. J Virol. Vol. 82, no. 10. (May): 5109-5114. (IF: 5.332)
  • Jonathan Honegger, Mona Prasad, David Colombo, David Bowen, Christopher Walker. 2008. HCV-specific T-cell responses during acute Hepatitis C Virus infection in pregnancy [Abstract]. Retrovirology. Vol. 5, no. Supplement 1. London, UK: BioMed Central. (April 9): O8-O8. http://www.retrovirology.com/content/5/S1/O8. [Non-Refereed] (Published)
  • Tagliabue C, Salvatore CM, Techasaensiri C, Mejías A, Torres JP, Katz K, Gomez A.M, Esposito S, Principi N, Hardy R.D. 2008. Combined Macrolide/Steroid Therapy is Superior to Either Therapy Alone in Experimental Mycoplasma pneumoniae Respiratory Infection.  J Infect Dis. Vol. 198, no. 15. : 1-9.
  • Perez-Yarza, E.G, Moreno A, Lazaro P, Ramilo O and Mejias A. 2008. Asthma after early RSV infection. How to control?.  Ped Infect Dis J. Vol. 27, no. 2. : 192.
  • Ramilo O and Mejías A. 2008. RSV Infections: New Strategies vs Old Challenges.  Anales Españoles de Pediatría. Vol. 69, no. 1. : 1-4.
  • Bhoj VG, Sun Q, Bhoj E, Somers C, Chen X, Torres JP, Mejías A, Gomez A, Jafri H, Ramilo O, Chen Z. J. 2008. MAVS and MyD88 Are Essential for Innate Immunity But Not Cytotoxic T Lymphocyte Response Against Respiratory Syncytial Virus.  Proc Natl Acad Sci U S A. Vol. 105, no. 37. : 14046-14051.
  • Burns J.C, Best B.M, Mejías A, Mahony L, Melish M. E, Jackson M.A, Asmar B, Lang D, Connor J, Keenan G, Ramilo O. 2008. Infliximab treatment of IVIG-resistant Kawasaki disease.  J Peds. Vol. 153, no. 6. : 833-838.
  • Chaussabel, D., Quinn, C., Shen, J., Patel, P., Glaser, C., Baldwin, N., Stichweh, D. Bennett, L., Allantaz, F., Mejías A., Ardura, M., Kaizer, E., Monnet, L., Allman, W., Randall, H., Punaro, M., Wittkowski, KM., White P., Fay, J., Klintmalm, G., Ramilo, O., Palucka, A.K., Banchereau, J. and Pascual, V. 2008. A modular framework for biomarker and knowledge discovery from blood transcriptional profiling studies: application to systemic lupus erythematosus.  Immunity. Vol. 29, no. 1. : 150-164.
  • Mejías A., Chávez-Bueno S, Gomez A, Estripeaut D, Torres J.P, Somers C, Jafri H.S and Ramilo O. 2008. Respiratory syncytial virus persistence: Evidence in the mouse model.  Ped Infect Dis J. Vol. 27, no. 10. : S60-S62.
  • Saavedra-Lozano J, Mejías A, Ahmad N, Peromingo E, Ardura M.I, Guillen S, Syed A, Cavuoti D, Ramilo O. 2008. Changing Trends in Acute Osteomyelitis in Children: Impact of Methicillin-Resistant Staphylococcus Aureus Infections.  J Ped Orthopaedics. Vol. 28, no. 5. : 569-575.
  • Gill M.A, Long K, Kwon T, Muñiz L, Mejías A, Connolly J, Roy L, Banchereau J and Ramilo O. 2008. Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza and respiratory syncytial virus infections.  J Infect Dis. Vol. 198, no. 11. : 1667-1676.
  • Mejias A. and Ramilo O. 2008. Review of palivizumab in the prophylaxis of Respiratory Syncytial Virus (RSV) in high risk infants.  Biologic Targets and Therapy. Vol. 2, no. 3. : 433-439.
  • Estripeaut D, Torrres JP, Somers C, Tagliabue C, Khokhar S, Bohj V.G, Grube S, Wozniakowski A, Gomez A, Ramilo O, Jafri H and Mejías A. 2008. Respiratory Syncytial Virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.  J Infect Dis. Vol. 198. : 1435-1443.

2007

  • Honegger J, Potter C, Cawthon D, WalkerC. 2007. Intrahepatic Cellular Immunity in Vertically Acquired Hepatitis C Virus Infection. [Abstract]. PIDS. (February) (Published)
  • Chavez-Bueno S, Mejías A, Ahmad N, Merryman R, Jafri H.S, Ramilo O. IntravenousPalivizumab. 2007. IntravenousPalivizumab and Ribavirin Combination for Treatment of Respiratory Syncytial Virus Disease in High-Risk Pediatric Patients.  Pediatr Infect Dis. Vol. 26, no. 12. : 1089-1093.
  • Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS Jr, Bakaletz LO, Durbin RK, Flaño E, Durbin JE. 2007. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo.  J Virol. Vol. 81, no. 18: 9790-9800. (IF: 5.308)
  • Weslow-Schmidt JL, Jewell NA, Mertz SE, Simas JP, Durbin JE, Flaño E. 2007. Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection.  J Virol. Vol. 81, no. 18: 9778-9789. (IF: 5.308)
  • Hallak L.K., Kwilas S.A., Peeples M.E. 2007. Interaction between Respiratory Syncytial Virus and Glycosaminoglycans, Including Heraran Sulfate. In In Sugrue, Glycovirology Protocols. Totowa: The Humana Press. 15-34.
  • Cush SS, Anderson KM, Ravneberg DH, Weslow-Schmidt JL, Flaño E. 2007. Memory generation and maintenance of CD8+ T cell function during viral persistence.  J Immunol. Vol. 179, no. 1: 141-153. (IF: 6)
  • Mejias A. and Ramilo O. 2007. RSV and Asthma up-to-date. The role of genomics.  Anales Españoles de Pediatría. Vol. 66, no. Suppl 2. : 63-68.
  • Ardura M.I, Mejías A, Gaynor-Katz K., Revell P, McCracken G.H and Sanchez P.J. 2007. Daptomycin therapy for Invasive Gram-positive Bacterial Infections in Children.  Pediatr Infect Dis. Vol. 26, no. 12. : 1128-1132.

2006

  • Moore, P.E., Cunningham, G., Calder, M.M., Dematteo, Jr A.D., Peeples, M.E., Summar, M.L., Peebles, Jr R.S. 2006. Respiratory syncytial virus infection reduces B2-adrenergic responses in human airway smooth muscle. Am. J. Respir. Cell Mol. Biol, no. 35: 559-564.
  • Laliberte, J.P., McGinnes, L.W., Peeples, M.E., and Morrison, T.G. 2006. Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles. J. Virol, no. 80: 10652-10662.
  • Sidney, John; Asabe, Shinichi; Peters, Bjoern; Purton, Kelly-Anne; Chung, Josan; Pencille, Timothy, J; Purcell, Robert; Walker, Christopher, M; Chisari, Francis, V; Sette, Alessandro. 2006. Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules. Immunogenetics. Vol. 58, no. 7: 559-70.
  • Pantua H.D., McGinnes, L.W., Peeples, M.E., and Morrison, T.G. 2006. Requirements for the assembly and release of Newcastle disease virus-like particles. J. Virol, no. 80: 11062-11073.
  • Martinez-Sobrido, L., Gitiban, N., Fernandez-Sesma, A., Cros, J., Mertz, S.E., Jewell, N.A., Hammond, S., Flaño, E., Durbin, R.K., Garcia-Sastre, A., Durbin, J.E. 2006. Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector.  J Virol. Vol. 80: 1130-1139. (IF: 5.308)
  • Guerrero-Plata, A., Casola, A., Suarez, G., Xiang, Y., Spech, L., Peeples, M.E., and Garofalo, R.P. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol., no. 34: 320-309.
  • Bowen, David G.; Cawthon, Andrew G.; Honegger, Jonathan R.; Rutkiewicz, Jennifer; Murthy, Krishna K.; Walker, Christopher M. 2006. High-level Hcv replication during acute infection occurring in the absence of reversion of previously acquired cytotoxic T lymphocyte escape mutations.  Hepatology. Vol. 44, no. 4, Suppl. 1. : 296A.
  • Mejías A and Ramilo O. 2006. RSV: New approaches to reduce the burden of RSV infection.  Drug Discovery Today Therapeutic Strategies. Vol. 3, no. 2. : 173-181.
  • Chávez-Bueno S., Mejías A. and Welliver R.C. 2006. RSV Bronchiolitis. Current and Future strategies for Prophylaxis.  Treat Respir Med. Vol. 5, no. 6. : 483-494.
  • Grakoui A, Wherry EJ, Hanson, HL, Walker CM, Ahmed R. 2006. Turning on the off switch: regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway. J Hepatol. Vol. 45, no. 4: 468-472.
  • Guerrero-Plata, A., Casola, A., Suarez, G., Xiang, Y., Spech, L., Peeples, M.E., and Garofalo, R.P. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.  Am. J. Respir. Cell Mol. Biol., no. 34: 309-320.
  • Bowen D, Cawthon A, Honegger J, Rutkiewicz J, Murthey K, Walker, C. 2006. High-level HCV replication during acute infection in the absence of reversion of previously acquired cytotoxic T lymphocyte escape mutations [Abstract]. Hepatology. Vol. 44, no. no 4, Suppl. 1: 296A. (Published)
  • Lemon SM, Walker CM, Alter MJ, Yi M. 2006. Hepatitis C Viruses. In Fields Virology. 5th ed. Vol. One. Edited by Knipe DM and Howley PM. Philadelphia, PA, USA: Lippincott Williams & Wilkins. 1253-1304.

2005

  • Mejías A., Chávez-Bueno S and Ramilo O. 2005. Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness.  Current Opinion in Infectious Diseases. Vol. 18, no. 3. : 199-204.
  • Chávez-Bueno S., Mejías A., Jafri H.S. and Ramilo O. 2005. Respiratory Syncytial Virus: Old Challenges and New Approaches.  Pediatric Annals. Vol. 34, no. 1. : 62-68.
  • Bowen, David, G; Walker, Christopher M. 2005. The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?. Journal of hepatology. Vol. 42, no. 3: 408-17.
  • Kimura, Yoichi; Gushima, Toshifumi; Rawale, Sharad; Kaumaya, Pravin; Walker, Christopher M. 2005. Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection. Journal of virology. Vol. 79, no. 8: 4870-6.
  • Flaño, E., Jia, Q., Moore, J., Woodland, D.L., Sun, R. and Blackman, M.A. 2005. Early establishment of gamma-herpesvirus latency: implications for immune control.  J Immunol. Vol. 174: 4972-4978. (IF: 6)
  • Bowen, David, G; Walker, Christopher M. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. Vol. 436, no. 7053: 946-52.
  • Bowen, David, G; Walker, Christopher M. 2005. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. The Journal of experimental medicine. Vol. 201, no. 11: 1709-14.
  • Mejías A., Chávez-Bueno S and Sánchez P.J. 2005. Respiratory Syncytial Virus Prophylaxis.  NeoReviews. Vol. 6, no. 1. : e26-e31.
  • Zhang, L., Bukreyev, A., Thompson, C.I., Watson, B., Peeples, M.E., Collins, P.L., and Pickles, R.J. 2005. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.  J. Virol.,, no. 79: 1113-1124.
  • Mejías A. Chávez-Bueno S., Jafri H.S. and Ramilo O. 2005. RSV Infections: Old Challenges and New Opportunities.  Pediatric Infectious Diseases Journal. Vol. 24, no. 11S. : S189-S197.
  • Flaño, E., Basak, K., Woodland, D.L. and Blackman, M.A. 2005. Infection of dendritic cells by a ?-herpesvirus induces functional modulation.  J Immunol. Vol. 175: 3225-3234. (IF: 6)
  • Gower, T.L., Pastey, M.K., Peeples, M.E., Collins, P.L., McCurdy, L.H., Hart, T.K., Guth, A., Johnson, T., and Graham, B.S. 2005. RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.  J. Virol.,, no. 79: 5326-5336.

2004

  • Shoukry, Naglaa, H; Cawthon, Andrew, G; Walker, Christopher M. 2004. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annual review of microbiology. Vol. 58: 391-424.
  • San-Juan-Vergara, H., Peeples, M.E., Lockey, R.F., and Mohapatra, S.S. 2004. Protein kinase C-? activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells.  J. Virol., no. 78: 13717-13726.
  • Tenorio, A.R., Peeples, M.E., Patri, M., Rezai, K., and Trenholme, G.M. 2004. Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccines and revaccinees.  Clinical and Diagnostic Laboratory Immunology, no. 11: 758-761.
  • Flaño, E., Hardy, C.L., Kim, I.J., Frankling, C., Coppola, M.A., Nguyen, P., Woodland, D.L., and Blackman, M.A. 2004. T cell reactivity during infectious mononucleosis and latent stages of ?-herpesvirus infection in mice.  J Immunol. Vol. 172: 3078-3085. (IF: 6)
  • Shoukry, Naglaa, H; Sidney, John; Sette, Alessandro; Walker, Christopher M. 2004. Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections. Journal of immunology (Baltimore, Md. : 1950). Vol. 172, no. 1: 483-92.
  • Kong, X., San Juan, H., Behera, A., Peeples, M.E., Wu, J., Lockey, R.F., Mohapatra, S.S. 2004. ERK-1/2 activity is required for efficient RSV infection.  FEBS Letters, no. 559: 33-38.
  • Elkington, Rebecca; Shoukry, Naglaa, H; Walker, Susan; Crough, Tania; Fazou, Chrysa; Kaur, Amitinder; Walker, Christopher, M; Khanna, Rajiv. 2004. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. European journal of immunology. Vol. 34, no. 11: 3216-26.
  • Larsson M, Babcock E, Grakoui A, Shoukry NH, Rice C, Walker CM and Bhardwaj N. 2004. Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. J Virol. Vol. 78: 6151-6161.
  • Meyer-Olson, Dirk; Shoukry, Naglaa, H; Brady, Kristen, W; Kim, Helen; Olson, Douglas, P; Hartman, Kelly; Shintani, Ayumi, K; Walker, Christopher, M; Kalams, Spyros A. 2004. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. The Journal of experimental medicine. Vol. 200, no. 3: 307-19.
  • Mejías A. Chávez-Bueno S., Ríos A.M., M. Fonseca Aten, A.M Gómez, H.S. Jafri and O. Ramilo. 2004. RSV and Asthma. New Opportunities of Therapeutic Intervention.  Anales Españoles de Pediatría. Vol. 61, no. 3. : 252-260.
  • Sundaram, Roshni; Lynch, Marcus, P; Rawale, Sharad; Dakappagari, Naveen; Young, Donn; Walker, Christopher, M; Lemonnier, Francois; Jacobson, Steven; Kaumaya, Pravin T P. 2004. Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus. Journal of acquired immune deficiency syndromes (1999). Vol. 37, no. 3: 1329-39.
  • Mejías A., Chavez-Bueno S. and Ramilo O. 2004. Human Metapneumovirus: A Not so new Virus. CME review.  Pediatric Infectious Disease Journal. Vol. 23, no. 1. : 1-10.

2003

  • Sette, Alessandro; Sidney, John; Livingston, Brian, D; Dzuris, John, L; Crimi, Claire; Walker, Christopher, M; Southwood, Scott; Collins, Edward, J; Hughes, Austin L. 2003. Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution. Immunogenetics. Vol. 54, no. 12: 830-41.
  • Shoukry, Naglaa, H; Grakoui, Arash; Houghton, Michael; Chien, David, Y; Ghrayeb, John; Reimann, Keith, A; Walker, Christopher M. 2003. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. The Journal of experimental medicine. Vol. 197, no. 12: 1645-55.
  • Borrego-Diaz, E., Peeples, M.E., Markosyan, R.M., Melikyan, G.B., and Cohen, F.S. 2003. Completion of trimeric hairpin formation of influenza virus hemagglutinin is critical for the transition from hemifusion to fusion.  Virology, no. 316: 234-244.
  • Kim, I-J., Flaño, E., Woodland, D.L., Lund, F.E., Randall, T.D. and Blackman, M.A. 2003. Maintenance of long-term ? -herpesvirus B cell latency is dependent on CD40-mediated development of memory B cells.  J Immunol. Vol. 171: 886-892.
  • Sundaram, Roshni; Sun, Yiping; Walker, Christopher, M; Lemonnier, Francois, A; Jacobson, Steven; Kaumaya, Pravin T P. 2003. A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design. Vaccine. Vol. 21, no. 21-22: 2767-81.
  • Macrae, A.I., Usherwood, E.J., Husain, S.M., Flaño, E., Kim, I.J., Woodland, D.L., Nash, A.A., Blackman, M.A., Sample, J.T. and Stewart, J.P. 2003. MHV-68 M2 protein is a B cell-associated antigen important for latency but not lymphocytosis. J Virol. Vol. 77: 9700-9709.
  • Mejías A, and Ramilo O. 2003. Asthma and RSV.  Anales Españoles de Pediatría. Vol. 58, no. 1. : 87-88.
  • Flaño, E., Kim, I-J., Woodland, D.L. and Blackman, M.A. 2003. Differential ? -herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol. Vol. 170: 3828-3834.
  • Barretto, N., Hallak, L., and Peeples, M.E. 2003. Neuraminidase treatment of respiratory syncytial virus-infected cells or virions, but not target cells, enhances cell-cell fusion and infection.  Virology, no. 313: 33-43.
  • Woollard, David, J; Grakoui, Arash; Shoukry, Naglaa, H; Murthy, Krishna, K; Campbell, Katherine, J; Walker, Christopher M. 2003. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee. Hepatology (Baltimore, Md.). Vol. 38, no. 5: 1297-306.
  • Grakoui, Arash; Shoukry, Naglaa, H; Woollard, David, J; Han, Jin-Hwan; Hanson, Holly, L; Ghrayeb, John; Murthy, Krishna, K; Rice, Charles, M; Walker, Christopher M. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science (New York, N.Y.). Vol. 302, no. 5645: 659-62.
  • Meyer-Olson, Dirk; Brady, Kristen, W; Blackard, Jason, T; Allen, Todd, M; Islam, Sabina; Shoukry, Naglaa, H; Hartman, Kelly; Walker, Christopher, M; Kalams, Spyros A. 2003. Analysis of the TCR beta variable gene repertoire in chimpanzees: identification of functional homologs to human pseudogenes. Journal of immunology (Baltimore, Md. : 1950). Vol. 170, no. 8: 4161-9.

2002

  • Flaño, E., Kim, I.J., Woodland, D.L., and Blackman, M.A. 2002. ? -Herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med. Vol. 196: 1363-1372.
  • Blackman, M.A. and Flaño, E. 2002. Persistent gammaherpesvirus infections: what can we learn from an experimental mouse model?. J Exp Med. Vol. 195: F29-F32.
  • Zhang, L., Peeples, M.E., Boucher, R., Collins, P.L., Pickles, R. 2002. Respiratory syncytial virus infection of human airway epithelial airway cells is polarized, specific to ciliated cells, and without obvious cytopathology.  J. Virol., no. 76: 5654-5666.
  • Davis NL, West A, Reap E, MacDonald G, Collier M, Dryga S, Maughan M, Connell M, Walker CM, McGrath K, Cecil C, Ping L-H, Frelinger J, Olmsted R, Keith P, Swanstrom R, Williamson C, Johnson P, Montefiori D, and Johnston RE. 2002. Alphavirus replicon particles as candidate HIV vaccines. JUBMB Life. Vol. 53: 209-211.
  • Walker CM. 2002. Cell-mediated immunity and the outcome of HCV infection in chimpanzees. In Frontiers in Viral Hepatitis. Edited by Schinazi RF, Rice C and Sommadossi J-P. Amsterdam, Netherlands: Elsevier Science. 59-70.
  • Kim, I.-J., Flaño, E., Woodland, D.L., Blackman, M.A. 2002. Antibody-mediated control of persistent ? -herpesvirus infection. J Immunol. Vol. 168: 3958-3964.
  • Fearns, R., Peeples, M.E. and Collins, P.L. 2002. Mapping the transcription and replication promoters of respiratory syncytial virus.  J. Virol, no. 76: 1663-1672.
  • Techaarpornkul, S., Collins, P.L., and Peeples, M.E. 2002. Respiratory syncytial virus containing the fusion protein as its only glycoprotein attaches to cells via either glycosaminoglycans or another molecule.  Virology, no. 294: 296-304.
  • Mejías A. and Ramilo O. 2002. Asthma and RSV. Myth or truth?.  Anales Españoles de Pediatría. Vol. 57, no. 3. : 199-204.

2001

  • Woodland, D.L., Usherwood, E.J., Liu, L., Flaño, E., Kim, I.-J., Blackman, M.A. 2001. Vaccination against murine ? -herpesvirus infection. Viral Immunol. Vol. 14: 217-226.
  • Paliard, ; XDoe, B; Selby, M, J; Hartog, K; Lee, A, Y; Burke, R, L; Walker, C M. 2001. Induction of herpes simplex virus gB-specific cytotoxic T lymphocytes in TAP1-deficient mice by genetic immunization but not HSV infection. Virology. Vol. 282, no. 1: 56-64.
  • Buck, C, B; Shen, ; XEgan, M, A; Pierson, T, C; Walker, C, M; Siliciano, R F. 2001. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. Journal of virology. Vol. 75, no. 1: 181-91.
  • Flaño, E., Woodland, D.L., Blackman, M.A., Doherty, P.C. 2001. Analysis of virus-specific CD4+ T cells during long-term gammaherpesvirus infection. J Virol. Vol. 75: 7744-7748.
  • Sutherland, K.A., Collins, P.L., and Peeples, M.E. 2001. Synergistic effects of gene-end signal mutations and the M2-1 protein on transcription termination by respiratory syncytial virus.  Virology, no. 288: 295-307.
  • Hardy, C.L., Flaño, E., Cardin, R.C., Kim, I.-J., Nguyen, P., King, S., Woodland, D.L., Blackman, M.A. 2001. Factors controlling CD8+ T cell activation associated with murine ?-herpesvirus-induced infectious mononucleosis.  Viral Immunol. Vol. 14: 391-402.
  • Phuangsab, A., Lorence, R.M., Reichard, K.W., Peeples, M.E., and Walter, R.J. 2001. Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration.  Cancer Letters, no. 172: 27-36.
  • Woodland, D. L., Flaño, E., Usherwood, E. J., Liu, L., Kim, I.-J., Husain, S. M., Sample, J. T., and Blackman, M. A. 2001. Antigen expression during murine ? -herpesvirus infection.  Immunobiology. Vol. 204: 649-658.
  • Flaño, E, Woodland, D.L., Blackman, M.A. 2001. A mouse model for infectious mononucleosis. Immunologic Research. Vol. 24: 353-369.
  • Erickson, A, L; Kimura, Y; Igarashi, S; Eichelberger, J; Houghton, M; Sidney, J; McKinney, D; Sette, A; Hughes, A, L; Walker, C M. 2001. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity. Vol. 15, no. 6: 883-95.
  • Techaarpornkul, S., Barretto, N., and Peeples, M.E. 2001. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the SH and/or G glycoprotein genes.  J. Virol, no. 75: 6825-6834.
  • Gower, T.L., Peeples, M.E., Collins, P.L., Graham, B.S. 2001. Rho A is activated during respiratory syncytial virus infection.  Virology, no. 283: 188-196.

2000

  • Hallak, L.K., Collins, P.L., Knudson, W. and Peeples, M.E. 2000. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.  Virology, no. 271: 264-275.
  • McKinney, D, M; Erickson, A, L; Walker, C, M; Thimme, R; Chisari, F, V; Sidney, J; Sette, A. 2000. Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs. Journal of immunology (Baltimore, Md. : 1950). Vol. 165, no. 8: 4414-22.
  • Flaño, E., Husain, S.M., Sample, J.T., Woodland, D.L., Blackman, M.A. 2000. Latent murine ?-herpesvirus infection is established in activated B cells, dendritic cells and macrophages. J Immunol. Vol. 165: 1074-1081.
  • Peeples, M.E. and Collins, P.L. 2000. Mutations in the 5'-trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step.  J. Virol, no. 74: 146-155.
  • Paliard, ; XLiu, Y; Wagner, R; Wolf, H; Baenziger, J; Walker, C M. 2000. Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS research and human retroviruses. Vol. 16, no. 3: 273-82.
  • Blackman, M.A., Flaño, E., Usherwood, E., Woodland, D.L. 2000. Murine ?-herpesvirus-68, a model for infectious mononucleosis?. Molec Med Today. Vol. 6: 488-490.
  • Hallak, L.K., Spillmann, D., Collins, P.L., and Peeples, M.E. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.  J. Virol, no. 74: 10508-10513.
  • McIntosh, D., Austin, B., Flaño, E., Villena, A., Martinez-Pereda, J.A., Tarazona, J.V. 2000. Lack of uptake of Renibacteriaum salmoninarum by gill epithelia of rainbow trout (Onchorhynchus mykiss, Walbaum). J Fish Biology. Vol. 56: 1053-1061.
  • Sidney, J; Dzuris, J, L; Newman, M, J; Johnson, R, P; Kaur, A; Amitinder, K; Walker, C, M; Appella, E; Mothe, B; Watkins, D, I; Sette, A. 2000. Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. Journal of immunology (Baltimore, Md. : 1950). Vol. 165, no. 11: 6387-99.
  • Fearns, R., Collins, P.L. and Peeples, M.E. 2000. Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus.  J. Virol, no. 74: 6006-6014.

1999

  • Ohnimus, H; Heinkelein, M; Heeney, J, L; Walker, C, M; Jassoy, C. 1999. Lysis of HIV envelope glycoprotein-expressing cells by CD4+ T lymphocytes from chimpanzees. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. Vol. 20, no. 2: 207-13.
  • Walker CM. 1999. Hepatitis C Virus. In Persistent Viral Infections. Edited by Chen I and Ahmed R. New York, NY, USA: Wiley Press. 93-115.
  • Liu, L., Flaño, E., Usherwood, E.J., Surman, S.L., Blackman, M.A., Woodland, D.L. 1999. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J Immunol. Vol. 163: 868-874.
  • Cooper, S; Erickson, A, L; Adams, E, J; Kansopon, J; Weiner, A, J; Chien, D, Y; Houghton, M; Parham, P; Walker, C M. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity. Vol. 10, no. 4: 439-49.
  • Coppola, M.A., Flaño, E., Nguyen, P., Hardy, C.L., Cardin, R.D., Shastri, N., Woodland, D.L., Blackman, M.A. 1999. MHC-independent stimulation of CD8+ T cells in vivo during latent murine ?-herpesvirus infection. J Immunol. Vol. 163: 1481-1489.
  • Jaovisidha, P., Peeples, M.E., Brees, A., Carpenter, L.R. and Moy, J.N. 1999. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release.  J. Immunology, no. 163: 2816-2820.
  • Furchner, M; Erickson, A, L; Allen, T; Watkins, D, I; Sette, A; Johnson, P, R; Walker, C M. 1999. The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule. Journal of virology. Vol. 73, no. 10: 8035-9.
  • Flaño, E., Woodland, L.D., Blackman, M.A. 1999. Requirement for CD4+T cells in Vb4+CD8+ T cell activation associated with latent murine gammaherpesvirus infection. J Immunol. Vol. 163: 3403-3408.
  • Selby, M; Erickson, A; Dong, C; Cooper, S; Parham, P; Houghton, M; Walker, C M. 1999. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules. Journal of immunology (Baltimore, Md. : 1950). Vol. 162, no. 2: 669-76.

1998

  • Barnett, S, W; Klinger, J, M; Doe, B; Walker, C, M; Hansen, L; Duliege, A, M; Sinangil, F M. 1998. Prime-boost immunization strategies against HIV. AIDS research and human retroviruses. Vol. 14 Suppl 3: S299-309.
  • Atreya, P.L., Peeples, M.E., and Collins, P.L. 1998. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.  J. Virol, no. 72: 1452-1461.
  • Flaño, E., López-Fierro, P., Alvarez, F., Razquin, B., Villena, A. 1998. Splenic cultures from rainbow trout, Oncorhynchus mykiss: establishment and characterisation. Fish Shellfish Immunol. Vol. 8: 589-606.
  • Olivo, P.A., Collins, P.L., Peeples, M.E., and Schlessinger, S. 1998. Detection and quantitation of human respiratory syncytial virus (RSV) using minigenome cDNA and a Sindbis virus replicon: A prototype assay for negative-strand RNA viruses.  Virology, no. 251: 198-205.
  • Cooper, S; Adams, E, J; Wells, R, S; Walker, C, M; Parham, P. 1998. A major histocompatibility complex class I allele shared by two species of chimpanzee. Immunogenetics. Vol. 47, no. 3: 212-7.
  • Selby M, Walker CM and Ulmer JB. 1998. Mechanisms of action of DNA vaccines. Exp Opin Invest Drugs. Vol. 7: 1987-1995.
  • Schroder, M.B., Flaño, E., Pilstrom, L., Jorgensen, T.O. 1998. Localisation of plasma cells in Atlantic cod (Gadus morhua L.) tissues; identified by is situ hybridisation.  Fish Shellfish Immunol. Vol. 8: 565-576.
  • Hernanz Moral, C., Flaño del Castillo E., Lopez Fierro, P., Villena Cortes, A., Anguita Castillo, J., Cascon Soriano, A., Sanchez Salazar, M., Razquin Peralta, B., Naharro Carrasco, G. 1998. Molecular characterization of the Aeromonas hydrophila aroA gene and potential use of an auxothrophic aroA mutant as live attenuated vaccine. Infect Immunity. Vol. 66: 1813-1821.
  • Paliard, ; XDoe, B; Walker, C M. 1998. The T cell repertoire primed by antiviral vaccination is influenced by self-tolerance. Cellular immunology. Vol. 188, no. 1: 73-9.

1997

  • Walker, C M. 1997. Comparative features of hepatitis C virus infection in humans and chimpanzees. Springer seminars in immunopathology. Vol. 19, no. 1: 85-98.
  • McIntosh, D., Flaño, E., Grayson, T.H., Gilpin, M.L., Austin, B., Villena, A. 1997. Production of putative virulence factors by Renibacterium salmoninarum grown in cell culture.  Microbiol. Vol. 134: 3349-3356.
  • Selby, M, J; Doe, B; Walker, C M. 1997. Virus-specific cytotoxic T-lymphocyte activity elicited by coimmunization with human immunodeficiency virus type 1 genes regulated by the bacteriophage T7 promoter and T7 RNA polymerase protein. Journal of virology. Vol. 71, no. 10: 7827-31.
  • Manning, W, C; Paliard, ; XZhou, S; Pat Bland, M; Lee, A, Y; Hong, K; Walker, C, M; Escobedo, J, A; Dwarki, V. 1997. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. Journal of virology. Vol. 71, no. 10: 7960-2.
  • Walker CM. 1997. Cell-mediated immunity in the persistence and pathogenesis of Hepatitis C virus infection: What can be learned from the chimpanzee model? In Treatments in Hepatology. Edited by Arroyo V, Bosch J, Rodes J. Barcelona, Spain: Masson, S.A. 133-138.
  • Fearns, R., Peeples, M.E., and Collins, P.L. 1997. Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome.  Virology, no. 236: 188-201.
  • Barnett, S, W; Rajasekar, S; Legg, H; Doe, B; Fuller, D, H; Haynes, J, R; Walker, C, M; Steimer, K S. 1997. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine. Vol. 15, no. 8: 869-73.
  • Flaño, E., López-Fierro, P., Razquin, B., Villena, A. 1997. In vitro proliferation of eosinophilic granular cells in gill cultures from rainbow trout. Fish Shellfish Immunol. Vol. 7: 519-521.

1996

  • Paliard, ; XLee, A, Y; Walker, C M. 1996. RANTES, MIP-1 alpha and MIP-1 beta are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones. AIDS (London, England). Vol. 10, no. 12: 1317-21.
  • Doe, B; Walker, C M. 1996. HIV-1 p24 Gag-specific cytotoxic T-lymphocyte responses in mice. AIDS (London, England). Vol. 10, no. 7: 793-4.
  • Flaño, E., López-Fierro, P., Razquin, B.E., Villena, A. 1996. In vitro differentiation of eosinophilic granular cells in Renibacterium salmoninarum-infected gill cultures from rainbow trout. Fish Shellfish Immunol. Vol. 6: 173-184.
  • Mehdi, H., Yang, X., and Peeples, M.E. 1996. An altered form of apolipoprotein H binds hepatitis B surface antigen most efficiently.  Virology, no. 217: 58-66.
  • Flaño, E., Kaattari, S.L., Razquin, B., Villena, A. 1996. Histopathology of the thymus of coho salmon, Oncorhynchus kisutch, experimentally infected with Renibacterium salmoninarum.  Diseases Aquatic Organisms. Vol. 26: 11-18.
  • Cooper, S; Kowalski, H; Erickson, A, L; Arnett, K; Little, A, M; Walker, C, M; Parham, P. 1996. The presentation of a hepatitis C viral peptide by distinct major histocompatibility complex class I allotypes from two chimpanzee species. The Journal of experimental medicine. Vol. 183, no. 2: 663-8.
  • Saifuddin, M., Parker, C.J., Peeples, M.P., Gorney, M.K., Zolla-Pazner, S., Ghassemi, M., Rooney, I.A., Atkinson, J.P., Spear, G.T. 1996. Role of virion-associated glycosylphosphatidyl-inositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.  J. Exper. Med. no. 217. : 58-66.
  • Kowalski, H; Erickson, A, L; Cooper, S; Domena, J, D; Parham, P; Walker, C M. 1996. Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees. The Journal of experimental medicine. Vol. 183, no. 4: 1761-75.
  • Alvarez, F., Flaño, E., Castillo, A., López-Fierro, P., Razquin, B., Villena, A. 1996. Tissue distribution of barrier cells in the hematopoietic and lymphoid organs of salmonids.  Anatomical Record. Vol. 245: 17-24.
  • Flaño, E., Alvarez, F., López-Fierro, P., Razquin, B., Villena, A., Zapata, A. 1996. In vitro and in situ characterisation of fish thymic nurse cells.  Dev Immunol. Vol. 26: 11-18.
  • Flaño, E., López-Fierro, P., Razquin, B., Kaattari, S.L., Villena, A. 1996. Histopathology of the renal and splenic haemopoietic tissues of coho salmon, Oncorhynchus kisutch, experimentally infected with Renibacterium salmoninarum.  Diseases Aquatic Organisms. Vol. 24: 107-115.
  • Mehdi, H., Tan, G.T., Pezzuto, J.M., Fong, H.H.S., Farnsworth, N.R., El-Feraly, F.S., Al-Yahya, M.A., Mossa, J.S., Peeples, M.E., Kernan, M.R., Rozhon, E.J. 1996. Cell culture assay system for the evaluation of natural product-mediated anti-hepatitis B virus activity.  Phytomedicine, no. 3: 369-377.
  • Walker CM. 1996. Cytotoxic T-lymphocyte responses to the hepatitis C virus in humans and chimpanzees. Seminars in Virology. Vol. 7: 13-21.
  • Doe, B; Selby, M; Barnett, S; Baenziger, J; Walker, C M. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proceedings of the National Academy of Sciences of the United States of America. Vol. 93, no. 16: 8578-83.

1995

  • Rice, C, M; Walker, C M. 1995. Hepatitis C virus-specific T lymphocyte responses. Current opinion in immunology. Vol. 7, no. 4: 532-8.
  • Weiner, A; Erickson, A, L; Kansopon, J; Crawford, K; Muchmore, E; Hughes, A, L; Houghton, M; Walker, C M. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proceedings of the National Academy of Sciences of the United States of America. Vol. 92, no. 7: 2755-9.
  • Wang, C. and Peeples, M.E. 1995. Intracellular maturation of the Newcastle disease virus fusion protein is affected by strain differences in the predicted amphipathic ?-helix adjacent to the fusion domain.  Virology, no. 208: 827-831.

1994

  • Mehdi, H., Kaplan, M.J., Anlar, F.Y., Yang, X., Bayer, R., Sutherland, K., and Peeples, M.E. 1994. Hepatitis B virus surface antigen binds to apolipoprotein H.  J. Virol, no. 68: 2415-2424.
  • Alvarez, F., Flaño, E., Villena, A., Zapata, A., Razquin, A. 1994. Seasonal intrathymic erythropoietic activity in trout. Develop Comparative Immunol. Vol. 18: 409-420.
  • Doe, B; Steimer, K, S; Walker, C M. 1994. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. European journal of immunology. Vol. 24, no. 10: 2369-76.
  • Hsueh, F, W; Walker, C, M; Blackbourn, D, J; Levy, J A. 1994. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Cellular immunology. Vol. 159, no. 2: 271-9.
  • Erickson, A, L; Walker, C M. 1994. An epitope in the V1 domain of the simian immunodeficiency virus (SIV) gp120 protein is recognized by CD8+ cytotoxic T lymphocytes from an SIV-infected rhesus macaque. Journal of virology. Vol. 68, no. 4: 2756-9.
  • Lorence, R.M., Katubig, B.B., Reichard, K.W., Reyes, H.M., Phuangsab, A., Sassetti, M.D., Walter, R. J., and Peeples, M.E. 1994. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.  Cancer Research, no. 54: 6017-6021.
  • Lorence, R.M., Reichard, K.W., Katubig, B.B., Reyes, H.M., Phuangsab, A., Mitchell, B.R., Cascino, C.J., Walter, R.J., and Peeples, M.E. 1994. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy.  J. Natl. Cancer Inst, no. 86: 1228-1233.

1993

  • Sergel, T., McGinnes, L.W., Peeples, M.E. and Morrison, T.G. 1993. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.  Virology, no. 193: 717-726.
  • Walker, C M. 1993. Non-cytolytic control of HIV replication by CD8+ T cells. Seminars in immunology. Vol. 5, no. 3: 195-201.
  • Coleman, N. and Peeples, M.E. 1993. The matrix protein of Newcastle disease virus localizes to the nucleus via a bipartite nuclear localization signal.  Virology, no. 195: 596-607.
  • Erickson, A, L; Houghton, M; Choo, Q, L; Weiner, A, J; Ralston, R; Muchmore, E; Walker, C M. 1993. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. Journal of immunology (Baltimore, Md. : 1950). Vol. 151, no. 8: 4189-99.
  • Anderson, K.M., Peeples, M.E. Kessler, H., and Harris, J.E. 1993. Neither ETYA nor A63162 inhibit Newcastle disease, herpes simplex or simian virus 40 replication: implications for their mechanism of action.  Clin. Physiol. Biochem., no. 10: 65-70.
  • Reichard, K.W., Katubig, B.B., Reyes, H.M., Peeples, M.E. and Lorence, R.M. 1993. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.  J. Ped. Surg., no. 28: 1221-1226.
  • Erickson, A, L; Walker, C M. 1993. Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans. The Journal of general virology. Vol. 74 ( Pt 4): 751-4.
  • Sellar, G.C., Keane, J., Mehdi, H., Peeples, M.E., Browne, N. and Whitehead, A.S. 1993. Characterization and acute phase modulation of canine apolipoprotein H ( 2-glycoprotein I).  Biochem. Biophys. Res. Comm., no. 191: 1288-1293.
  • Melikyan, G.B., Niles, W.D., Peeples, M.E. and Cohen, F.S. 1993. Influenza hemagglutinin-mediated fusion pores connecting cells to planar membranes: flickering to final expansion.  J. Gen. Physiol, no. 102: 1131-1149.

1992

  • Peeples, M.E., Wang, C., Gupta, K.C. and Coleman, N. 1992. Nuclear entry and nucleolar localization of the Newcastle disease virus (NDV) matrix protein occurs early in infection and does not require other NDV proteins.  J. Virol, no. 66: 3263-3269.
  • Wang, C., Raghu, G., Morrison, T. Peeples, M.E. 1992. Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain.  J. Virol, no. 66: 4161-4169.
  • Reichard K.E., Lorence R.M., Casono C.J., Peeples M.E., Walter R.J., and Reyes H.M. 1992. N-myc oncogene enhances the sensitivity of neuroblastoma to killing by Newcastle disease virus. In Surgical Forums. Chicago: American College of Surgeons. 603-606.
  • Reichard, K.W., Lorence, R.M., Cascino, C.J., Peeples, M.E., Walter, R.J., Fernando, M.B., Reyes, H.M. and Greager, J.A. 1992. Newcastle disease virus selectively kills human tumor cells.  J. Surg. Res, no. 52: 448-453.
  • Nelson, J.A., Wolf, M.D., Yuh, W.T.C. and Peeples, M.E. 1992. Cranial nerve involvement with Lyme borreliosis demonstrated by magnetic resonance imaging.  Neurology, no. 42: 671-673.
  • Wolf, M.D., Folk, J.C., Nelson, J.A. and Peeples, M.E. 1992. Acute posterior multifocal placoid pigment epitheliopathy and Lyme disease.  Arch. Ophthalmol, no. 110: 750.
  • Perot, K; Walker, C, M; Spaete, R R. 1992. Primary chimpanzee skin fibroblast cells are fully permissive for human cytomegalovirus replication. The Journal of general virology. Vol. 73 ( Pt 12): 3281-4.
  • Walker CM, Selby M, Erickson A, Cataldo D, Valensi JP and Van Nest GA. 1992. Cationic lipids deliver a viral glycoprotein into the class I MHC antigen presentation pathway. Proc Natl Acad Sci USA. Vol. 89: 7915-7918.

1991

  • Walker, C, M; Thomson-Honnebier, G, A; Hsueh, F, C; Erickson, A, L; Pan, L, Z; Levy, J A. 1991. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cellular immunology. Vol. 137, no. 2: 420-8.
  • Mehdi, H., Nunn, M., Steel, D.M., Whitehead, A.S., Perez, M., Walker, L. and Peeples, M.E. 1991. Nucleotide sequence and expression of the human gene encoding apolipoprotein H (B2-glycoprotein I).  Gene, no. 108: 293-298.
  • Walker, C, M; Erickson, A, L; Hsueh, F, C; Levy, J A. 1991. Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. Journal of virology. Vol. 65, no. 11: 5921-7.
  • Nelson, J.A., Bouseman, J.K., Kitron, U., Callister, S.M., Harrison, B., Bankowski, M.J., Peeples, M.E., Newton, B.J. and Anderson, J.F. 1991. Isolation and characterization of Borrelia burgdorferi from Illinois Ixodes dammini.  J. Clin. Microbiol, no. 29: 1732-1734.
  • Castro, B, A; Walker, C, M; Eichberg, J, W; Levy, J A. 1991. Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. Cellular immunology. Vol. 132, no. 1: 246-55.

1990

  • Levy JA, Mackewicz CE, and Walker CM. 1990. Primary HIV-1 infection (letter). N Engl J Med. Vol. 325: 734.
  • Wiviott, L, D; Walker, C, M; Levy, J A. 1990. CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cellular immunology. Vol. 128, no. 2: 628-34.
  • Nelson, J.A., Bankowski, M.J., Newton, B.J., Benson, C.A., Kaplan, R., Landau, W., Trenholme, G.M. and Peeples, M.E. 1990. Detection of antibodies in late lyme disease.  J. Infect. Dis., no. 177: 332-338.
  • Niles, W.D., Peeples, M.E. and Cohen, F.S. 1990. Kinetics of virus-induced hemolysis measured for single erythrocytes.  Virology, no. 174: 593-598.
  • Komai, K. and Peeples, M.E. 1990. B virus surface antigen particles are internalized by Vero cells.  Virology, no. 177: 332-338.

1989

  • Walker, C, M; Moody, D, J; Stites, D, P; Levy, J A. 1989. CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cellular immunology. Vol. 119, no. 2: 470-5.
  • Walker, C M. 1989. How do CD8+ T lymphocytes control HIV replication in vivo?. Research in immunology. Vol. 140, no. 1: 115-8; discussion 122.
  • Pontisso, P., Petit, M.-A., Bankowski, M.J. and Peeples, M.E. 1989. Human liver membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region.  J. Virol, no. 63: 1981-1988.
  • Walker, C, M; Levy, J A. 1989. A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology. Vol. 66, no. 4: 628-30.
  • Castro, B, A; Walker, C, M; Tateno, M; Cheng-Mayer, C; Heberling, R; Eichberg, J, W; Levy, J A. 1989. Human immunodeficiency virus (HIV) from experimentally infected chimpanzees: isolation and characterization. Journal of medical primatology. Vol. 18, no. 3-4: 337-42.

1988

  • Cowan MJ, Walker CM, Culver K, Weintrub PS, Wara DW, and Levy JA. 1988. Maternally transmitted human immunodeficiency virus infection in children. AIDS. Vol. 2: 437-441.
  • Faaberg, K.S. and Peeples, M.E. 1988. Association of the soluble matrix protein of Newcastle disease virus with liposomes is independent of ionic conditions.  Virology, no. 166: 123-132.
  • Komai, K., Kaplan, M. and Peeples, M.E. 1988. The Vero cell receptor for the hepatitis B virus small S protein is a sialoglycoprotein.  Virology, no. 163: 629-634.
  • Peeples, M.E. 1988. Differential detergent treatment allows immunofluorescent localization of the matrix protein of Newcastle disease virus within the nucleus of infected cells.  Virology. no. 162. : 255-259.
  • Peeples, M.E., Glickman, R.L., Gallagher, J.P. and Bratt, M.A. 1988. Temperature-sensitive mutants of Newcastle disease virus altered in HN glycoprotein size, stability, or antigenic maturity.  Virology. no. 164. : 284-289.
  • Faaberg, K.S. and Peeples, M.E. 1988. Strain variation and nuclear location of the Newcastle disease virus matrix protein.  J. Virol, no. 62: 586-593.
  • Walker CM, Steimer KS, Rosenthal KL, Levy JA. 1988. Identification of HIV-1 envelope type-specific T helper cells in an HIV-infected individual. J Clin Invest. Vol. 82: 2172-2175.

1987

  • Pontisso P, Bankowski M.J., Petit M.A., and Peeples M.E. 1987. Recombinant HBsAg particles cotaining pre-S proteins bind to human liver plasma membranes. In Hepadna Viruses. New York: W. Robinson, K. Koike and H. Will. 205-221.
  • Morrison, T.G., Peeples, M.E. and McGinnes, L.W. 1987. Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption.  Proc. Natl. Acad. Sci., U.S.A., no. 84: 1020-1024.
  • Peeples M.E. 1987. A ts mutant of Newcastle disease virus that is defective in F cleavage and antiboly binding under nonpermissive conditions. In The Biology of Negative Strand Viruses. New York: Elsevier Biomedical Press. 81-88.
  • Peeples, M.E., Komai, K., Radek, R. and Bankowski, M.J. 1987. A cultured cell receptor for the small S protein of hepatitis B virus.  Virology, no. 160: 135-142.

1986

  • Rosenthal, K, L; Steiner, C; Rawls, W, E; Walker, C M. 1986. Studies concerning the relationship of Pichinde virus-induced natural killer cells and cytotoxic T lymphocytes. Medical microbiology and immunology. Vol. 175, no. 2-3: 133-6.
  • Walker, C, M; Moody, D, J; Stites, D, P; Levy, J A. 1986. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science (New York, N.Y.). Vol. 234, no. 4783: 1563-6.

1985

  • Walker, C, M; Paetkau, V; Rawls, W, E; Rosenthal, K L. 1985. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2. Journal of immunology (Baltimore, Md. : 1950). Vol. 135, no. 2: 1401-7.
  • Clark DA, Chaput A, Walker CM and Rosenthal KL. 1985. Soluble suppressor activity obtained from murine decidua blocks the response to IL2. J Immunol. Vol. 134: 1659.

1984

  • Peeples, M.E. and Bratt, M.A. 1984. Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporated into virion particles and decreased infectivity.  J. Virol, no. 51: 81-90.
  • Peeples M.E., and Bratt M.A. 1984. Mapping mutant and wild-type M proteins of Newcastle disease virus (NDV) by repeated partial proteolysis. In Nonsegmented Negative Strand Viruses. New York: Academic Press. 315-320.
  • Walker CM, Rawls WW, Rosenthal KL. 1984. Generation of memory cell-mediated immune responses following secondary infection of mice with Pichinde virus. J Immunol. Vol. 132: 469.

1983

  • Peeples, M.E., Glickman, R.L. and Bratt, M.A. 1983. Thermostabilities of virion activities of Newcastle disease virus: evidence that the temperature-sensitive mutants in groups B, BC, and C have altered HN proteins.  J. Virol, no. 45: 18-26.

1982

  • Peeples, M.E., Rasenas, L.L. and Bratt, M.A. 1982. RNA synthesis by Newcastle disease virus temperature-sensitive mutants in two RNA-negative complementation groups.  J. Virol, no. 42: 996-1006.
  • Peeples, M.E. and Bratt, M.A. 1982. UV irradiation analysis of complementation between, and replication of, RNA-negative temperature-sensitive mutants of Newcastle disease virus.  J. Virol, no. 41: 965-973.
  • Peeples, M.E. and Bratt, M.A. 1982. Virion functions of RNA+ temperature-sensitive mutants of Newcastle disease virus.  J. Virol, no. 42: 440-446.

1981

  • Peeples, M.E. and Levine, S. 1981. Characteristics of a persistent respiratory syncytial virus infection in HeLa cells.  Virology, no. 113: 141-149.
  • Peeples M.E., Gallagher J.P., and Bratt M.A. 1981. Permissive temperature analysis of RNA temoerature-sensitive mutants of Newcastle disease virus. In The Replication of Negative Strand Viruses. New York: Elsevier North Holland, Inc. 567-572.

1980

  • Peeples, M. and Levine, S. 1980. Metabolic requirements for the maturation of respiratory syncytial (RS) virus.  J. Gen. Virol, no. 50: 81-88.

1979

  • Peeples, M. and Levine, S. 1979. Respiratory syncytial virus polypeptides: their location in the virion.  Virology, no. 95: 137-145.

1978

  • Peeples, M.E. 1978. Studies on the polypeptide structure, the metabolic requirements for maturation, and persistence of respiratory syncytial (RS) virus in HeLa cell culture.  Doctoral Dissertation.

1977

  • Levine, S., Peeples, M. and Hamilton, R. 1977. The effect of respiratory syncytial virus infection on HeLa-cell macromolecular synthesis.  J. Gen. Virol, no. 37: 53-63.

  • Somers C, Naveed A, Mejías A, Buckingham S. C, Carubelli C, Katz-Gaynor K, Leos N, Gomez A, DeVincenzo J.P, Ramilo O, Jafri H.S. Effect of dexamethasone on RSV-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial. Ped Allergy and Immunol 2009: 20 (5):477-85.
    Read abstract »
    PubMed ID: 19397752
  • Mejías A, Bustos R, Ardura M, Ramírez C, Sánchez PJ. Persistence of Herpes Simplex Virus DNA in Cerebrospinal Fluid of Neonates with Herpes Simplex Virus Encephalitis. J Perinatol 2009 (4): 290-6.
    Read abstract »
    PubMed ID: 19194454
  • Estripeaut D, Torrres JP, Somers C, Tagliabue C, Khokhar S, Bohj V.G, Grube S, Wozniakowski A, Gomez A, Ramilo O, Jafri H and Mejías A. Respiratory Syncytial Virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis 2008; 198: 1435-43.
    Read abstract »
    PubMed ID: 18828742
  • Mejías A, Chavez-Bueno S, Raynor M.B, Connolly J, Kiener P.A, Jafri HS, Ramilo O. Motavizumab, an enhanced anti-respiratory syncytial virus (RSV) neutralizing monoclonal antibody significantly modifies the local and systemic cytokine responses induced by RSV in the mouse model. Virol J 2007; Oct 25; 4(1):109.
    Read abstract »
    PubMed ID: 17961258
  • G. Pérez-Yarza E, Moreno A, Lazaro P, Mejías A and Ramilo O. The Association between Respiratory Syncytial Virus Infection and the Development of Childhood Asthma: A Systematic Review of the Literature. Pediatric Infectious Diseases Journal 2007; 26: 733-39.
    Read abstract »
    PubMed ID: 17848887
  • Mejías A, Chávez-Bueno S. Ríos A.M, Fonseca Aten M., Raynor B., Peromingo E., Soni P., Olsen K.D, Kiener, PA, Gómez A.M, Jafri H.S. and Ramilo O. Comparative Effect of Two Neutralizing anti-RSV Monoclonal Antibodies in the Respiratory Syncytial Virus Murine Model. Time versus Potency. Antimicrobial Agents and Chemotherapy 2005: 49 (11): 4700-7.
    Read abstract »
    PubMed ID: 16251314
  • Mejías A., Chávez-Bueno S and Ramilo O. Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness. Current Opinion in Infectious Diseases 2005: 18(3): 199-204.
    Read abstract »
    PubMed ID: 15864095
  • Mejías A. Chávez-Bueno S., Ríos A.M., Saavedra-Lozano J., Fonseca-Aten M., Hatfield J., Kapur P., Gómez A.M, Jafri H.S. and Ramilo O. Anti-RSV Neutralizing Antibody decreases lung inflammation, airway obstruction and airway hyperresponsiveness in the Respiratory Syncytial Virus model. Antimicrobial Agents and Chemotherapy 2004: 48 (5); 1811-1822.
    Read abstract »
    PubMed ID: 15105140
  • Honegger JR, Presenter. 2008. Maternal Immunity to the Hepatitis C Virus. Presented at Immunology Journal Club/Work in Progress. The Research Institute at Nationwide Children's Hospital. Columbus, OH, USA. (September)
  • Honegger JR, Presenter. 2007. Perinatal HIV and Hepatitis Infections. Presented at Neonatal Nurse Practitioner Lecture. Columbus Children's Hospital. Columbus, OH, USA. (April)
  • Honegger JR, Presenter. 2008. Relatively New Adolescent Immunizations. Presented at Grand Rounds. The Ohio State University. Columbus, OH, USA. (April)
  • Honegger J, Lecturer. 2010. Neonatal Sepsis. Presented at Chairman's Case Conference for Pediatric Medical Students. Nationwide Children's Hospital. Columbus, OH, USA. (July)
  • Honegger JR, Presenter. 2009. Adaptive Immune Features of Natural Killer Cells. Presented at Immunology Journal Club. The Research Institute at Nationwide Children's Hospital. Columbus, OH, USA. (June)
  • Honegger JR, Prasad M, Colombo D, Bowen D, Potter C, and Walker CM, Presenter. 2008. T-cell Immunity to Hepatitis C Virus Infection During Pregnancy. Presented at Research Institute Annual Retreat. Nationwide Children's Hospital. Columbus, OH, USA. (March)
  • Honegger JR, Presenter. 2007. Viral Hepatitis. Presented at Housestaf Conference. Columbus Children's Hospital. Columbus, OH, USA. (April)
  • Honegger J, Walker C, Chair. 2011. Hepatitis C in Pregnancy and Vertical Transmission. Presented at Nationwide Children's Hospital Gastroenterology Morning Conference. Nationwide Children's Hospital. Columbus, OH, USA. (July 14)
  • Jonathan Honegger, Lecturer. 2009. Postpartum Surge in T-cell Immunity to the Hepatitis C Virus. Presented at NIH (NICHD) Child Health Research Centers Annual Retreat. Seattle, WA. (September)
  • Hallak L.K. and Peeples M.E. filed 2006. (patent pending) Unrestricted Mutagenesis and Cloning Methods. patent no. US60/849,977.
  • Honegger JR, Presenter. 2010. Perinatal and Pediatric HIV. Presented at Housestaff Conference. Nationwide Children's Hospital. Columbus, OH, USA. (May)
  • Honegger JR, Presenter. 2008. Maternal and Infant T-cell Immunity to the Hepatitis C Virus. Presented at Clinical Research Seminar. The Research Institute at Nationwide Children's Hospital. Columbus, OH, USA. (June)
  • Peeples M.E., Kennedy M., and Ray W. filed 2007. (patent pending) Methods and Compositions Relating to Viral Fusion Proteins. patent no. US2008/66223.
  • Honegger JR, Kohout J, Kim S, Lemon S, Grakoui A, Walker C, Poster Presenter. 2011. Reversion of cytotoxic T-cell escape mutation during pregnancy permits vertical transmission of most fit hepatitis C variant. Presented at 18th International Meeting on Hepatitis C and Related Viruses. Seattle, WA, USA. (September)
  • Olivo, P.D., Schlesinger, S., Peeples, M.E., and Collins, P.L. filed 1997 and issued 2001. Detection of Negative-Strand RNA Viruses. patent no. 6,270,958.
  • Jonathan Honegger, Lecturer. 2009. Postpartum Surge in T-cell Immunity to the Hepatitis C Virus. Presented at Infectious Diseases Society of America Annual Meeting. Philadelphia, PA, USA. (October)
  • Honegger JR, Presenter. 2011. Perinatal and Pediatric HIV. Presented at Housestaff Conference. Columbus, OH, USA. (October)
  • Honegger JR, Presenter. 2010. Viral Hepatitides. Presented at Pediatric Infectious Diseases Fellow Lecture. Nationwide Children's Hospital. Columbus, OH, USA. (January)
  • Olivo P.D., Collins P.L., and Peeples M.E. filed 2004 and issued 2009. Negative Strand Virus Replicon. patent no. US2004/018783.
  • Honegger JR, Lecturer. 2008. Primary Immunodeficiences. Presented at Integrated Biomedical Graduate Program Course 703 Lecture. The Ohio State University. Columbus, OH, USA. (April)
  • Honegger JR, Prasad M, and Walker CM, Presenter. 2007. Hepatitis C: Transmission from Mother to Baby. Presented at Pediatric Grand Rounds. Columbus Children's Hospital. Columbus, OH, USA. (April)
  • Honegger JR, Presenter. 2008. Perinatal and Pediatric HIV. Presented at Housestaff Conference. Nationwide Children's Hospital. Columbus, OH, USA. (December)
  • Jonathan Honegger, Lecturer. 2009. Preventing Mother to Child Transmission of the Hepatitis C Virus. Presented at BOSS Seminar. Nationwide Children's Hospital. Columbus, OH. (May)
  • Honegger J, Prasad M, Kohout J, Walker C., Poster Presenter. 2010. Influence of Pregnancy on Hepatitis C Virus Evolution. (Postor Presentation). Presented at 17th International Meeting on Hepatitis C and Related Viruses. Yokohama, Japan. (September)
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000